NIMH Celebrates 75 Years of Innovation: MBF Bioscience Featured in Anniversary Blog

MBF Bioscience >  Blog > Additional Subject Matter  > Company News  > NIMH Celebrates 75 Years of Innovation: MBF Bioscience Featured in Anniversary Blog

NIMH Celebrates 75 Years of Innovation: MBF Bioscience Featured in Anniversary Blog

The National Institute of Mental Health (NIMH) commemorated its 75th anniversary with a Director’s message on June 20th, 2024, highlighting its unwavering commitment to advancing mental health technology through its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.


Since their inception, NIMH’s SBIR/STTR programs have been a catalyst for numerous small businesses, propelling them to become global leaders or attractive acquisition targets. Notable early beneficiaries include Acadia Pharmaceuticals, Alkermes, and Neurocrine Biosciences, among others.


MBF Bioscience, originally known as MicroBrightField, stands out as a shining example of NIMH’s successful investment in innovation. As a pioneer in developing cutting-edge microscopy and image analysis software for neuroscience research, MBF has transformed the landscape of brain structure and function studies. Our state-of-the-art tools have become indispensable to researchers worldwide, significantly advancing our collective understanding of neurological and psychiatric disorders. The impact of MBF’s contributions is evidenced by the impressive tally of nearly 20,000 peer-reviewed publications that have utilized our products in their research.


In recognition of its outstanding contributions, MBF Bioscience, along with several other NIMH-funded businesses, has been honored with the prestigious Tibbetts Award from the U.S. Small Business Administration. This accolade celebrates companies that exemplify the spirit of the SBIR/STTR programs through their economic, technical, and societal impact.


The success stories of MBF Bioscience and other NIMH-supported companies underscore the institute’s vital role in identifying and nurturing groundbreaking ideas from their inception. NIMH’s early-stage funding has been instrumental in bringing a multitude of innovative technologies and treatments to fruition, ultimately benefiting millions of individuals affected by mental health conditions.


As NIMH charts its course for the future, its ongoing support for small businesses through the SBIR and STTR programs promises to fuel the next wave of innovations in mental health technology and care delivery. The remarkable achievements of the past 75 years, exemplified by companies like MBF Bioscience, lay a solid foundation for continued growth and breakthroughs in this critical field.


The feature of MBF Bioscience in NIMH’s anniversary blog not only highlights our company’s achievements but also reinforces the importance of continued investment in mental health research and technology. As we move forward, we remain committed to pushing the boundaries of neuroscience research tools, inspired by NIMH’s enduring support and the potential to make a lasting impact on mental health care.


Read the article here: